RELL2 and breast carcinoma: Curiously, although experimental evidence demonstrates RELL2 possesses anti-tumorigenic activities in ESCC, PDAC, and breast cancer cell lines, bioinformatic analysis indicates that RELL2 expression is associated with poor outcomes in several cancers [83].